COLUMBIA, MD--(Marketwire - June 06, 2011) - Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it will hold its Annual Meeting of Shareholders on Friday, June 10, 2011 at 10:00 a.m. EDT at the Pier 5 Hotel, 711 Eastern Avenue, Baltimore, Maryland 21202.
Shareholders who are unable to attend the meeting are invited to participate by telephone. Please contact Marnie Masotti at 443-259-4894 for dial-in-information.
About Celsion Corporation
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Mayo Clinic, the University of Pisa, and the North Shore Long Island Jewish Health System.
For more information on Celsion, visit our website: http://www.celsion.com.
Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
